Brexit

The UK is to ratify the Unified Patent Court Agreement. That flies in the face of prime minister Theresa May’s pledge to be free of the EU Court of Justice - and hints at a ‘soft’ Brexit

With growth forecasts sharply down from before the referendum, the pledge to balance the budget by 2020 is abandoned. New borrowing will allow for a Keynesian-style splurge on infrastructure and R&D

According to new Nature Index, collaboration between scientists in the UK and those elsewhere in the EU increased over the past four years

Preparations for future €1B research project include several UK figures

Uncertainty over the future home of the EU’s drug regulator is impacting recruitment and staff motivation, director tells MEPs

Four months after the Brexit vote, the landscape is as uncertain for UK companies as on 24 June. The needs of life sciences must be understood and the sector given a bigger say in exit negotiations, says former health minister, Stephen Dorrell

Country joins the battle to host the EU's London-based drug agency after Brexit

Fall in the pound pushes up price of chemical reagents and lab equipment for UK researchers

Japanese government memo calls for an end to the uncertainty and sets out requirements of Japanese companies if they are to remain invested in the UK. The demands include the UK continuing to have access to EU R&D funds

Bruegel think-tank proposes a new plan for Britain which would limit researcher mobility but give greater influence over rule-making than is traditionally offered to non-EU members